Retraction: Santacruzamate A Ameliorates AD-Like Pathology by Enhancing ER Stress Tolerance Through Regulating the Functions of KDELR and Mia40-ALR in vivo and in vitro

Frontiers Editorial Office
DOI: https://doi.org/10.3389/fncel.2024.1505362
2024-10-09
Frontiers in Cellular Neuroscience
Abstract:This article is a retraction of: RETRACTED: Santacruzamate A Ameliorates AD-Like Pathology by Enhancing ER Stress Tolerance Through Regulating the Functions of KDELR and Mia40-ALR in vivo and in vitro
neurosciences
What problem does this paper attempt to address?